ORLOFF JOHN J 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Jun 11, 2019
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Tax Payment
Common Stock, par value $.0001 per share
2019-06-07$118.61/sh−2,786$330,447→ 37,791 total
Footnotes (1)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.